EPO published patent EP2820050A1 for Roquette Frères, covering hypoglycemic hyper-branched maltodextrins with IPC classifications including C08B 30/18 and A61K 31/718. The patent designates all EU/EEA member states and confers exclusive rights to the claimed maltodextrin compositions.

Pharmaceutical companies and investors should review the patent claims to assess potential infringement risks or licensing opportunities for similar maltodextrin-based products. Patent holders may need to monitor for competing applications in the same technical field. No immediate compliance actions are required as this is a publication of granted intellectual property rights.